Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma
Ling HeiD, Daria J. AzizadiD, Kruttika BhatiD, Angeliki IoannidisiD, Carter J. Hoffmann, Evelyn ArambulaiD, Mansoureh EghbaliiD, Aparna BhaduriiD, Harley I. KornblumiD, Frank PajonkiD
Abstract
Glioblastoma is the deadliest brain cancer in adults and almost all patients succumb to the tumor. While surgery followed by chemo-radiotherapy significantly delays disease progression, these treatments do not lead to long-term tumor control and targeted therapies or biologics have so far failed to further improve survival. Utilizing a transient radiation-induced state of multipotency we used the adenylcyclase activator forskolin to alter the cellular fate of glioma cells in response to radiation. The combined treatment induced the expression of neuronal markers in glioma cells, reduced proliferation and led to a distinct gene expression profile. scRNAseq revealed that the combined treatment forced glioma cells into a microglia- and neuron-like phenotypes. In vivo this treatment led to a loss of glioma stem cells and prolonged median survival in mouse models of glioblastoma. Collectively, our data suggest that revisiting a differentiation therapy with forskolin in combination with radiation could lead to clinical benefit.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 15
- FWCI
- 6.15
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sensitizing the Cell Killing Effects of Doxorubicin as a Possible Therapeutic Strategy Against Glioblastoma Multiforme
Anthony J. Berdis·bioRxiv·Dec 25, 2025
- Synergistic Effects of the DRD2/3 Antagonist ONC201 and Radiation in Glioblastoma
Ling He, Kruttika Bhat, … Frank Pajonk·Radiotherapy and OncologyPeer-reviewed·Jun 5, 2021
- Phenotypic Screening Identifies Flunarizine as an Inhibitor of Radiotherapy-Induced Astrocyte Reactivity with Therapeutic Potential in Glioblastoma
Pauline Jeannot, Rebecca Rosberg, … Alexander Pietras·bioRxiv·Jul 12, 2025
- Chronically radiation-exposed survivor glioblastoma cells display poor response to Chk1 inhibition
N. Pinarbasi Degirmenci, I. Sur-Erdem, … T. Bagci-Onder·bioRxiv·Apr 16, 2022
- The Dopamine Receptor Antagonist TFP Prevents Phenotype Conversion and Improves Survival in Mouse Models of Glioblastoma
Kruttika Bhat, Mohammad Saki, … Frank Pajonk·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2020
- Targeting Glioblastoma Cell State Plasticity for Enhanced Therapeutic Efficacy
Stéfano M. Cirigliano, Richa Singhania, … Howard Alan Fine·bioRxiv·Sep 8, 2025